Beth Israel Deaconess Medical Center Inc.
Boston, Massachusetts, United States
Purpose
to develop a novel HIV-1 RV144-like vaccine regimen using an improved vaccine vector Mycobacterium bovis Bacillus Calmette-Guerin
Division
Global Health
Date
October 2011
Region Served
GLOBAL
Committed amount
$8,958,936
Grant topic
HIV
Duration (months)
75
Grantee location
Boston, Massachusetts, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.